Bonnet Q, Coppens L, Delvigne A, Waltregny D
Service d'urologie, CHU de Liège, Liège, Belgique.
Service d'urologie, CHU de Liège, Liège, Belgique.
Prog Urol. 2020 Apr;30(5):281-287. doi: 10.1016/j.purol.2020.02.010. Epub 2020 Mar 17.
Study the early postoperative course of sperm parameters after antegrade sclerotherapy (AS) of clinical left varicocele (CLV) in men consulting for infertility with sperm disruption, and to validate the efficacy and safety of treatment.
Monocentric retrospective observational study of men with CLV, consultant in medically assisted procreation center for primary or secondary infertility of the couple. All patients were operated by SA via scrotal approach. After clinical and ultrasound checks at 6 weeks, a control spermogram was performed at 3-6 months of surgery. The following parameters were analyzed: sperm count, motility, percent of normal form, and total number of motile sperm ("total motile sperm count" [TMSC]).
The study involved 138 men (median age 33 years) with sperm alteration. All patients benefited from AS of their CLV. No Clavian complication > 1 was observed. Postoperative control demonstrated a significant improvement in all spermogram parameters, with a median progression of 40% of the count (55 vs 32×106), 80% of the concentration (20.3 vs 11.1×106/ml), 30% of the motility (34.7% vs 26.5%), 60% of the normal form percentage (4.0 vs 2.5%) and the 75% TMSC (41.5 vs 23%), 7×106) (p<0.005).
SA is an effective and safe technique for treating CLV and improving sperm parameters fertility indicators. Our results suggest that this treatment may be recommended to infertile men with CLV in the management of infertility of the couple.
研究临床左侧精索静脉曲张(CLV)患者在因精子异常而咨询不育问题时,行顺行硬化疗法(AS)后精子参数的早期术后变化过程,并验证该治疗方法的有效性和安全性。
对CLV男性患者进行单中心回顾性观察研究,这些患者在医学辅助生殖中心因夫妇原发性或继发性不育前来咨询。所有患者均通过阴囊途径接受AS手术。术后6周进行临床和超声检查,术后3 - 6个月进行对照精液分析。分析以下参数:精子计数、活力、正常形态百分比以及活动精子总数(“总活动精子计数”[TMSC])。
该研究纳入了138名(中位年龄33岁)精子异常的男性。所有患者均接受了CLV的AS治疗。未观察到大于1级的锁骨下并发症。术后对照显示所有精液分析参数均有显著改善,计数中位数进展40%(55对32×10⁶),浓度80%(20.3对11.1×10⁶/ml),活力30%(34.7%对26.5%),正常形态百分比60%(4.0对2.5%),TMSC 75%(41.5对23%,7×10⁶)(p<0.005)。
AS是治疗CLV并改善精子参数生育指标的有效且安全的技术。我们的结果表明,对于夫妇不育管理中患有CLV的不育男性,可推荐这种治疗方法。
3级